Literature DB >> 26929551

Prevalence of Functional Problems After Oral Cavity Malignancy Treatment at a Tertiary Center: Utilizing PSS HN (Performance Status Scale for Head and Neck) Scale.

Kaushal Yadav1, Deepa Nair2, Jaiprakash Agarwal3, Swagnik Chakrabarti2, Sanmit Joshi2, Pranav Ingole2, Aseem Mishra2, Nitin Tathe1, Pankaj Chaturvedi2.   

Abstract

BACKGROUND: Oral cancer is the most common type of cancer occurring in India and it is equally important to assess morbidities after treatment for optimal utilization of resources. Utilizing PSS HN we try to identify the patient population who are severely impaired and need aggressive rehabilitation. METHOD AND MATERIAL: The PSSHN questionnaire was administered by the treating physician to 100 consecutive oral cancer patients who completed their index treatment at least 6 months prior to accrual. Functional morbidities with score ≤50 were considered as significant.
RESULTS: Prevalence of functional deficit of eating in public; deficit of understandability of speech and deficit of normalcy of diet were 28, 13 and 38 % respectively.
CONCLUSION: Type of resection either segmental mandibulectomy or major glossectomy, had most significant impact on concerned functional deficits and surgeries involving these defects should be carefully planned to involve free flap reconstruction and proper postoperative rehabilitation.

Entities:  

Keywords:  Functional outcome; Oral Malignancies; PSS HN (Performance Status Scale for Head and Neck) scale; Quality of life

Year:  2015        PMID: 26929551      PMCID: PMC4759033          DOI: 10.1007/s12663-015-0805-2

Source DB:  PubMed          Journal:  J Maxillofac Oral Surg        ISSN: 0972-8270


  24 in total

1.  Are head and neck specific quality of life measures necessary?

Authors:  R E Gliklich; T A Goldsmith; G F Funk
Journal:  Head Neck       Date:  1997-09       Impact factor: 3.147

2.  Speech, deglutition and life quality after intraoral tumour resection. A prospective study.

Authors:  H Schliephake; R Schmelzeisen; R Schönweiler; T Schneller; C Altenbernd
Journal:  Int J Oral Maxillofac Surg       Date:  1998-04       Impact factor: 2.789

3.  Quality of life and recurrence concern in survivors of head and neck cancer.

Authors:  B H Campbell; A Marbella; P M Layde
Journal:  Laryngoscope       Date:  2000-06       Impact factor: 3.325

4.  A prospective study of quality of life in head and neck cancer patients. Part II: Longitudinal data.

Authors:  K Bjordal; M Ahlner-Elmqvist; E Hammerlid; M Boysen; J F Evensen; A Biörklund; M Jannert; T Westin; S Kaasa
Journal:  Laryngoscope       Date:  2001-08       Impact factor: 3.325

Review 5.  Speech and swallowing rehabilitation for head and neck cancer patients.

Authors:  J A Logemann; B R Pauloski; A W Rademaker; L A Colangelo
Journal:  Oncology (Williston Park)       Date:  1997-05       Impact factor: 2.990

6.  Prospective study of the quality of life of cancer patients after intraoral tumor surgery.

Authors:  H Schliephake; K Rüffert; T Schneller
Journal:  J Oral Maxillofac Surg       Date:  1996-06       Impact factor: 1.895

7.  A performance status scale for head and neck cancer patients.

Authors:  M A List; C Ritter-Sterr; S B Lansky
Journal:  Cancer       Date:  1990-08-01       Impact factor: 6.860

8.  Measuring quality of life in routine oncology practice improves communication and patient well-being: a randomized controlled trial.

Authors:  Galina Velikova; Laura Booth; Adam B Smith; Paul M Brown; Pamela Lynch; Julia M Brown; Peter J Selby
Journal:  J Clin Oncol       Date:  2004-02-15       Impact factor: 44.544

9.  Importance-rating using the University of Washington quality of life questionnaire in patients treated by primary surgery for oral and oro-pharyngeal cancer.

Authors:  S N Rogers; S H Laher; L Overend; D Lowe
Journal:  J Craniomaxillofac Surg       Date:  2002-04       Impact factor: 2.078

10.  Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma.

Authors:  M J Zelefsky; J Gaynor; D Kraus; E W Strong; J P Shah; L B Harrison
Journal:  Am J Surg       Date:  1996-02       Impact factor: 2.565

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.